Nkarta, Inc. (NKTX)
NASDAQ: NKTX · Real-Time Price · USD
2.975
-0.115 (-3.72%)
Apr 23, 2026, 4:00 PM EDT - Market closed
Nkarta Market Cap
Nkarta has a market cap or net worth of $209.59 million as of April 23, 2026. Its market cap has increased by 89.35% in one year.
Market Cap
209.59M
Enterprise Value
14.73M
1-Year Change
89.35%
Ranking
Category
Stock Price
$2.98
Market Cap Chart
Since July 10, 2020, Nkarta's market cap has decreased from $1.46B to $209.59M, a decrease of -85.68%. That is a compound annual growth rate of -28.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 22, 2026 | 220.29M | 67.64% |
| Dec 31, 2025 | 131.40M | -25.22% |
| Dec 31, 2024 | 175.72M | -45.75% |
| Dec 29, 2023 | 323.88M | 10.77% |
| Dec 30, 2022 | 292.39M | -42.19% |
| Dec 31, 2021 | 505.77M | -74.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adagene | 257.02M |
| Orchestra BioMed Holdings | 254.57M |
| Arcturus Therapeutics Holdings | 252.97M |
| Voyager Therapeutics | 252.11M |
| Milestone Pharmaceuticals | 250.20M |
| Codexis | 238.08M |
| Camp4 Therapeutics | 234.68M |
| Fennec Pharmaceuticals | 232.02M |